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Abstract— Malaria is a major public health problem caused by Plasmodium falciparum, a parasite that infects red blood cells. Recently, several 
polyphenolic compounds have been reported capable of preventing the progression of malaria parasite. This observation may be related to NAD 
(P) H: quinon oxidoreductase: a flavoprotein responsible for catalyzing two-electron reduction and detoxification of quinones and their derivatives. 
In this study the 2123 bp of the 5` upstream of the first transcription start site was successfully isolated. Based on the bioinformatic  program, 
several regulatory regions such as Antioxidant Response Element (ARE) may be responsible for the direct regulation of polyphenols on this 
enzyme. It was predicted at -477 from the first transcription start site. Upon isolation, this fragment was used in a cloning process into the pGL3 
Basic vector and transformed to E.coli DH5α competent cells. 
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1 INTRODUCTION                                                                     
The focus of this study was the isolation of NQO1 gene 
promoter and its constructs. It was fulfilled in order to explore 
the effect of certain polyphenols in regulation of gene 
expression for future work. In this paper, four sections will be 
described. In the first section, malaria as an infectious disease 
has been introduced. In the second section, several kinds of 
polyphenolic derivatives and the effects of these compounds 
on this disease have been reviewed. In the third section, 
NQO1gene, promoter, and regulatory sequences are 
discussed. Finally, the effect of polyphenolic compounds in 
regulation of gene expression related to transcription factors 
will be discussed. Malaria is one of the most destructive and 
dangerous parasitic infections in many tropical and subtropical 
countries [1]. Almost half of the world’s population lives under 
the risk of this disease. Malaria is caused by protozoan 
parasites of the genus Plasmodium. Four species of 
Plasmodium infect human and the most deadly is P. falciparum 
[9]. The infected Anopheles mosquito injects the sporozoites 
into human dermis. After inoculation, they migrate to liver cells 
and generate the merozoites. Then these cells invade 
erythrocytes (RBCs) and in this erythrocytic stage, a severe 
condition of malaria occurs. The life cycle is completed when a 
mosquito ingests gametocytes [5]. It has been proven that the 
malaria parasite generates a huge amount of reactive oxygen 
species (ROS) inside the infected erythrocytes. This is 
produced due to the oxidation and degradation of ingested 
hemoglobin in the acid environment of the parasite’s food 
vacuole. ROS causes oxidative and electrophilic stress, also 
membrane and DNA damage. The most crucial function of 
defensive system in body is its ability to control oxidative 
stress [4]. Reactive oxygen species are detoxified by the 
antioxidant mechanisms [7], [8].  
 
 
 
 
 
 
 
 
 
 
 
 
Polyphenols are hydroxylated phenolic compounds extracted 
from plants. Some of them (e.g., flavonoids) are known for 
their antioxidant and antiparasitic activities [3]. The antioxidant 
actions of polyphenols are principally because of their redox 
properties, which play a critical function in neutralizing and 
adsorbing free radicals. Luteolin is one of the polyphenolic 
compounds in plants, which prevent the progression of 
parasite growth beyond the young trophozoite stage. 
Therefore, the parasites are incapable to complete a full intra 
erythrocytic cycle [3]. In addition, Elagic acid is found in 
various plant products with antioxidant activities. It has shown 
high activity in vitro against all Plasmodium falciparum strains 
and affects the parasite growth in the mature trophozoite and 
young schizont stages [6]. Some enzymes protect the cells 
against oxidative stress. One of these antioxidant enzymes is 
NAD (P) H: quinone oxidoreductase (NQO1). NQO1 is a 
flavoprotein that catalyzes detoxification and two-electron 
reduction of quinones as well as its by-products. It protects the 
cells against oxidative stress and redox cycling [2]. NQO1 
gene expression is induced in response to some compounds 
such as oxidants, antioxidants, xenobiotics, UV light, heavy 
metals, and ionizing radiations [8]. Antioxidant response 
element (ARE) found in several gene promoter is activated by 
nuclear E2-related factors such as NF-E2-related factor2 
(Nrf2). It is an essential transcription factor in the management 
of detoxification and antioxidant protection as well as overall 
regulation of the protective response. Nrf2 has the ability to 
manage many different aspects of cellular protection [4]. ARE- 
transcription factor complex is necessitated for both induction 
and expression of NQO1 and other detoxifying enzyme genes. 
In this process, Nrf2 with c-Jun bind to the ARE and activate 
the gene expression [2]. 
 
2 METHODOLOGY 
2.1 Sequence Determination of NQO1 Promoter 
For designing the primers, the sequence of human NQO1 
gene and promoter were identified from National Center for 
Biotechnology Information (NCBI). 
 
2.2 Designing the Primers for the First PCR and With 
Restriction Enzymes Cutting Sites For Second PCR 
To isolate the promoter sequence, the primers were designed 
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using primer3 website ( http://frodo.wi.mit.edu/primer3/ ) 
(Table1) . The primers were aligned with sequence of NQO1 
promoter by using bioinformatic tools for assurance of primers 
correctness.  The enzymes chosen in this project were MluI 
and BglII with cutting sites ACGCGT and AGATCT respectively 
in the 5` ends of forward and reverse primers. The poly A sites 
were introduced to protect the restriction sites from damage 
and help the enzyme to digest the ends. PCR was carried out 
and the products extracted for digestion. 
 
2.3 Isolation of Genomic DNA from Human Blood 
Since mature red blood cells have no nucleus, DNA must be 
taken from either leukocytes, or immature and nucleated red 
blood cells. DNA extraction methods are universal, but some 
particular processes are necessary when working with blood, 
due to its delicate nature. Sample of human blood was taken 
and collected in EDTA tubes to prevent clotting and then the 
extraction process of DNA was done using Genomic DNA 
Purification Kit from Promega. The concentration and 
purification of DNA were determined by measuring the 
260/280nm absorbance ratio. Then Agarose gel 
electrophoresis was carried out to identify DNA fragments. 
 
2.4 PCR Amplification 
First sets of primer were used to amplify the NQO1 gene 
promoter. The specific bands were excised and extracted from 
the gel using QIAgen QIAquick Gel Extraction Kit to use as 
DNA sample for second PCR process. 
 
2.5 DNA Sequencing 
PCR product was sealed and sent to Medigene laboratory for 
sequencing. The result was compared with the sequence 
obtained from NCBI by using BLAST tool. 
 
2.6 Grow of E.coli on Plate and in Liquid Culture 
Growing of E.coli on agar plates or in liquid medium was 
initiated by using a single E.coli colony derived from the 
glycerol stock after streaking on agar plates. In order to 
transform the plasmid into the host, cells first needed to be 
competent. 
 
2.7 Preparation of PGL3-Basic Vector by QIAprep Spin 
Miniprep Kit 
Single colony was picked from a freshly streaked agar plate 
and was immersed in 5 ml LB containing with 50 µg/ml 
ampicillin. The culture was incubated in shaking incubator at 
37 °C/ 200 rpm overnight. After that, Plasmid was isolated 
using QIAprep Spin Miniprep Kit. 
 
2.8 Double digestion of PGL3-Basic Vector and NQO1 
promoter 
The gel purified PCR product (NQO1 gene promoter) and 
plasmid were digested simultaneously using appropriate 
ingredients and conditions by Promega. Two enzymes with 
100% compatibility in buffer “D”(Table2) were used.  
 
2.9 Ligation with T4 DNA ligase 
The digested insert (the NQO1 promoter) and PGL3 Basic 
vector were ligated with T4 DNA ligase using Promega kit. The 
solutions were mixed and incubated overnight at 4°C before 
being transformed into E.coli. 
 
2.10 Transformation of ligation reaction into Ecoli 
DH5alpha competent 
20 μl of the ligation reaction was transformed into 150 ml 
competent cells. Only transformed cells survived on the plates 
as they contained PGL3 with insert. 
 
3   RESULT AND DISCUSSION 
 
3.1 Sequence Identification of NQO1 Gene and 
Promoter 
The sequence of NQO1 gene and promoter were determined 
using NCBI database. The sequence length of NQO1 gene 
(Accession number NG_011504) was 24230bp and promoter 
(AY426763) was 2123bp (Figure1). The sequence of 
NQO1gene was aligned with promoter sequence by ClustalW2 
tool in European Bioinformatics Institute (EBI) websites. The 
specific forward and reverse primers were designed in primer3 
Input (version 0.4.0) and aligned with NQO1 promoter using 
Pairwise Alignment website 
 
 
 
 
 
 
 
 
TABLE 1 
 
 
Primer sequences for isolating human NQO1 promoter 
region and for introduction of restriction cutting sites 
TABLE 2 
 
Percent Activity in 4-CORE® Buffer System of MluI and BglII 
restriction enzymes  
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3.2 Characterization of Potential Transcription Factor 
Binding Sites within NQO1 Promoter 
The regulatory regions related to transcription factors for 
NQO1 gene promoter was analyzed using Mat Inspector ® 
software (Genomatix) and Japanese bioinformatics 
(http://www.cbrc.jp/research/db/TFSEARCH.html) 
 
3.3 Isolation of Genomic DNA from Human Blood 
Sample 
Genomic DNA was extracted from fresh blood by Genomic 
DNA Purification Kit.  5 μl of DNA was transferred to agarose 
gel and the band observed above the 1kb DNA ladder (Shown 
Figure 2) as the whole of genomic DNA in human is 
approximately 3 billion base pairs. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
As mentioned above the measuring of DNA concentration and 
purification was carried out using Nanodrop 
Spectrophotometer. The OD260: 280 ratio of purified DNA is 
found in the expected range of 1.8-2 ng/μl with concentration 
124 ng/ μl. An aliquot of 10 μl was transferred into the 10 
sterile 1.5 ml microcentrifuge tubes and stored at -20°C for 
using PCR. 
 
3.4 Polymerase Chain Reaction (PCR) 
PCR was successfully done to access and isolate the exact 
region of NQO1 gene promoter (Figure3). The PCR product 
were sent for sequencing. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The result was analyzed with Sequence Scanner software 
V1.0. The nucleotide sequence obtained was submitted for 
similarity search in the GeneBank database using BLAST 
NCBI with high similarity with Homo Sapien NAD(P)H 
dehydrogenase, Quinone 1 (NQO1) (Figure 4). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3.5 Amplification of Promoter Using Primers with 
Restriction Cutting Sites 
To insert DNA fragment into the vector, same primers with 
restriction enzyme binding sites were applied. Restriction sites 
for Mlu I and Bgl II were located in the 5` end of forward and 
reverse primer respectively. By using bioinformatic tools NEB 
 
Figure2. DNA extracted from blood .Lane M: 1kb Marker, Lane 1-3: 
Genomic DNA 
 
Figure3. PCR product of NQO1 promoter.M:1kb marker,      
  Lane 1-5 promoter fragments                
 
                                     
 
Figure4. Comparison between the isolated sequence and NCBI 
database for forward and reverse NQO1 promoter. The top and 
bottom panels show forward and reverse promoter sequence 
comparisons respectively. 
 
Figure1.Sequence of human NQO1 promoter. Number 1-2: 
Accession Number and length of NQO1 promoter  
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cutter (http://tools.neb.com/NEBcutter2/) it was confirmed that 
is no any restriction binding site inside the sequence for these 
enzymes; thus, they were good choices for cutting both ends 
of promoter from the gene. Figure 5 shows the amplified 
promoter with binding sites for Mlu I and Bgl II. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
PCR product with restriction enzyme binding sites was 
extracted from agarose gel to be digested for ligation into the 
PGL3 vector by T4 DNA ligase (Figure6). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The digested PCR fragment and pGL3 basic vector were 
ligated. After overnight incubation at 4°C, producing a circular 
product that was directly transformed into competent E.coli 
DH5α cells. The transformants were screened on LB-agar 
plate containing 50 μg/ml ampicillin. Figure7 shows the 
colonies, which were obtained from transformation after 16 
hours incubation at 37°C. These colonies may include the 
recombinant plasmid carrying the ampicilin resistance gene. 
To verify the accuracy of transformation, all process including 
isolation of plasmid from E. coli DH5α, digestion with same 
enzymes was done to get the NQO1gene promoter. 
Nucleotide sequence analysis of human NQO1 gene promoter 
revealed that several potential transcription factors binding 
sites are in the NQO1 promoter. Several transcription factors 
can bind to these binding sites and Nrf2 is the strongest 
activator in ARE-mediated NQO1 expression. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
4   CONCLUSION 
The sequence of NQO1 gene and promoter were determined 
with 24230bp and 2123bp. The regulatory sites of NQO1 
promoter for binding the transcription factors were 
characterized using bioinformatics. Primers with restriction 
cutting sites, which are same with pGL3 Basic vector cutting 
sites, isolated the promoter from genomic DNA. In this study 
we successfully isolated the 2123 bp from transcription start 
site believe to be involve in regulatory the transcription of 
NQO1 gene. Further investigation proposed potential 
regulatory regions named ARE located at -477 from the 
transcription start site. This regulatory region may be 
responsible in regulating the NQO1 gene expression by 
polyphenol and further work need to be conduct to validate 
this. 
 
5   FUTURE WORK 
Several constructs can be obtained and cloned into pGL3 
Basic vector using additional 5` flanking deletion of NQO1 
promoter. With these constructs it can be investigated the 
efficiency of selected polyphenols against the activity of NQO1 
gene based on down or up regulation, and possible 
transcription factors involved in the malaria infected 
erythrocyte. 
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Figure5. Ampilfied promoter with RE sites, M1&M2: marker, lane1-3 
before extraction, lane 4 after extraction. 
 
 
Figure6. Digested product of vector and promoter. M marker, 1: 
Promoter, 2: pGL3 
 
Figure7. Transformation of pGL3-NQO1 promoter into competent E. 
coli DH5α on LB with 50 μg/mL ampicillin and 4 is the negative 
control. 
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